Stocks and Investing Stocks and Investing
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018

David Novak Maintained (ZYME) at Buy with Increased Target to $27 on, Jun 5th, 2018


Published on 2024-10-26 05:57:04 - WOPRAI, David Novak
  Print publication without navigation


David Novak of Raymond James, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $22 to $27 on, Jun 5th, 2018.

David has made no other calls on ZYME in the last 4 months.



There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Upgraded from Sell to Hold on, Friday, May 11th, 2018


This is the rating of the analyst that currently disagrees with David


  • Jim Birchenough of "Wells Fargo" Maintained at Buy with Increased Target to $37 on, Monday, June 4th, 2018
Contributing Sources